De Novo Lipogenesis of Sebaceous Glands in Acne



Status:Recruiting
Conditions:Acne, Acne, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:15 - 45
Updated:7/1/2018
Start Date:October 2015
End Date:May 2019
Contact:Raja K Sivamani, MD
Email:rksivamani@ucdavis.edu
Phone:9167035145

Use our guide to learn which trials are right for you!

There are two purposes of this study:

1. First, the investigators want to see what the differences are in de novo sebaceous lipid
production of people with and without acne.

2. Secondly, the investigators want to know what happens to sebaceous gland de novo lipid
production before and after treatment with topical tretinoin and oral isotretinoin.

The primary objective of this study is to understand how de novo lipid production of
sebaceous glands are altered in acne and with acne directed therapy.

Hypothesis 1: The overall de novo lipogenesis will be increased in those with acne

Hypothesis 2: Treatment with topical tretinoin and systemic isotretinoin will reduce de novo
lipogenesis.

Inclusion Criteria:

- Age 15 to 45 years of age

- Subject/Parents/Legal Guardian be able to read and comprehend study procedure and
consent forms

- Have acne that is diagnosed by a board certified dermatologist

- Meet one of the following criteria:

- already been prescribed oral isotretinoin for treatment of acne

- have already been prescribed a topical retinoid

- eligible for prescription of topical tretinoin

Exclusion Criteria:

- Those who have already initiated or completed a course of systemic isotretinoin

- Those with seborrheic dermatitis, rosacea, or polycystic ovary syndrome

- Those who are pregnant in female participants

- Those who do not fit the inclusion criteria
We found this trial at
2
sites
Davis, California 95616
Principal Investigator: Raja K Sivamani, MD
Phone: 916-734-1509
?
mi
from
Davis, CA
Click here to add this to my saved trials
Sacramento, California 95816
?
mi
from
Sacramento, CA
Click here to add this to my saved trials